Incyte (INCY) Misses Q2 on Top and Bottom
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $123.28 -2.17%
EPS Growth %: -225.2%
Financial Fact:
Basic (in dollars per share): 0.2
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -225.2%
Financial Fact:
Basic (in dollars per share): 0.2
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q2 EPS of ($0.22), $0.27 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $99.58 million versus the consensus estimate of $140.72 million.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- RUM Group to raise Northern Data stake to ~98% via share purchase
- Adobe beats Q3 targets, but soft Q4 sales guidance triggers dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
